News
BNGOW
0.0036
0.00%
0.00
Analysts Offer Insights on Healthcare Companies: BioNano Genomics (BNGO), Liquidia Technologies (LQDA) and PolyPid (PYPD)
TipRanks · 3d ago
Bionano Genomics reports Q2 results
Seeking Alpha · 5d ago
Bionano Genomics Raises FY2026 Sales Guidance from $30.000M-$33.000M to $31.000M-$33.000M vs $32.137M Est
Benzinga · 5d ago
Bionano Genomics Sees Q3 Sales $8.200M-$8.600M vs $8.575M Est
Benzinga · 5d ago
Press Release: Bionano Reports Second Quarter 2026 Results and Provides a Business Update
Dow Jones · 5d ago
Here are the major earnings after the close Monday
Seeking Alpha · 5d ago
Weekly Report: what happened at BNGO last week (0803-0807)?
Weekly Report · 5d ago
Earnings Week Ahead: SMCI, CSCO, JD, PLUG, and more
Seeking Alpha · 6d ago
Bionano Genomics Q2 Earnings Preview
Seeking Alpha · 08/07 21:35
Weekly Report: what happened at BNGO last week (0727-0731)?
Weekly Report · 08/03 09:00
Weekly Report: what happened at BNGO last week (0720-0724)?
Weekly Report · 07/27 09:00
Weekly Report: what happened at BNGO last week (0713-0717)?
Weekly Report · 07/20 09:00
Weekly Report: what happened at BNGO last week (0706-0710)?
Weekly Report · 07/13 09:00
Weekly Report: what happened at BNGO last week (0629-0703)?
Weekly Report · 07/06 09:00
Weekly Report: what happened at BNGO last week (0622-0626)?
Weekly Report · 06/29 09:00
*Bionano Appoints Alex Hastie as Chief Scientific Officer
Dow Jones · 06/24 12:33
Press Release: Bionano Announces Hiring of Chief Scientific Officer
Dow Jones · 06/24 12:30
Press Release: Bionano Announces Hiring of Chief -2-
Dow Jones · 06/24 12:30
Weekly Report: what happened at BNGO last week (0615-0619)?
Weekly Report · 06/22 09:00
Bionano Genomics announces studies featuring OGM at 2026 conference
TipRanks · 06/18 12:39
More
Webull provides a variety of real-time BNGOW stock news. You can receive the latest news about Bionano Genomics through multiple platforms. This information may help you make smarter investment decisions.
About BNGOW
Bionano Genomics, Inc. is a provider of genome analysis solutions that can enable researchers and clinicians to reveal answers to challenging questions in biology and medicine. The Company offers optical genome mapping (OGM) solutions for applications across basic, translational and clinical research. It also offers a platform-agnostic software solution, which integrates sequencing and microarray data designed to provide analysis, visualization, interpretation and reporting of copy number variants, single-nucleotide variants, and absence of heterozygosity across the genome in one consolidated view. The Company additionally offers nucleic acid extraction and purification solutions using proprietary isotachophoresis (ITP) technology. The Company markets and sells OGM systems, including the Saphyr system, which delivers OGM data to enable ultra-sensitive and ultra-specific detection of all classes of structural variation (SV).